Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 6
Submit an article Journal homepage
732
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Bloodless chimeric antigen receptor (CAR) T-cell therapy in Jehovah’s Witnesses

Peter A. Riedella Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA;b David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2719-0580
ORCID Icon,
Meng Wuc Department of Medicine, University of Chicago, Chicago, IL, USA
,
Jennifer M. Collinsd Department of Pharmacy, University of Chicago, Chicago, IL, USA
,
Jacklyn M. Gideona Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA;b David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL, USA
,
Andrzej J. Jakubowiaka Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA;b David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL, USA
,
Justin P. Klinea Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA;b David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL, USA
,
Satyajit Kosuria Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA;b David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL, USA
,
Hongtao Liua Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA;b David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL, USA
,
Sonali M. Smitha Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA
&
Michael R. Bishopa Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA;b David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL, USAORCID Iconhttps://orcid.org/0000-0002-3979-9273
ORCID Icon show all
Pages 1497-1501 | Received 08 Nov 2020, Accepted 06 Jan 2021, Published online: 03 Feb 2021
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Disclosure statement

PAR receives research support from Kite/Gilead, Novartis, Celgene/BMS, MorphoSys, Calibr, has served on advisory boards or provided consulting for Bayer, Novartis, Kite/Gilead, Karyopharm, Verastem, BeiGene, Takeda, Celgene/BMS, and on speakers bureau for Bayer, and Kite/Gilead

MW reports no relevant conflicts of interest.

JMC reports no relevant conflicts of interest.

JMG has served on a speakers bureau for Sanofi Genzyme and BMS and has participated on advisory boards for Celgene

AJJ reports consulting and advisory boards for AbbVie, Amgen, BMS, GSK, Janssen, and Karyopharm Therapeutics Inc.

JPK receives research support from Merck, Verastem, and iTeos, has served on a speakers bureau for Kite/Gilead, and has served on advisory boards for Verastem, Seattle Genetics, MorphoSys, and Karyopharm

SK reports no relevant conflicts of interest.

HL received research support from BMS and Karyopharm, has served on advisory board meeting for Agios.

SMS received research support from FortySeven, TG Therapeutics, Pharmacyclics, Acerta, Celgene, Novartis, Genentech/Roche, Epizyme, has served as a consultant for Janssen, Bristol Myers Squibb, Bantam, Karyopharm, Genentech, Celgene, Bayer, and TG Therapeutics.

MRB receives research support from Kite/Gilead, Novartis, Arcellx, CRISPR Therapeutics, has served on advisory boards for Kite/Gilead, Novartis, Arcellx, CRISPR Therapeutics, Autolus, Juno, Takeda, and Celgene, and on speakers bureaus for BMS, Incyte, Sanofi, and Kite/Gilead.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.